Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Consulting agrmnt
Director departure
Appointed director
|
|
GeoVax Labs, Inc. (GOVX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/27/2023 |
4
| McKee Kelly T. Jr. (Chief Medical Officer) has filed a Form 4 on GeoVax Labs, Inc.|
Txns:
| Bought 9,653 shares
@ $0.52, valued at
$5k
|
|
| 08/21/2023 |
4
| Reynolds Mark (CFO) has filed a Form 4 on GeoVax Labs, Inc.|
Txns:
| Bought 10,000 shares
@ $0.5179, valued at
$5.2k
|
|
| 08/14/2023 |
4
| SPENCER JOHN N JR (Director) has filed a Form 4 on GeoVax Labs, Inc.|
Txns:
| Granted 50,000 options
@ $0.755, valued at
$37.8k
|
|
| 08/14/2023 |
4
| Morgan Jayne (Director) has filed a Form 4 on GeoVax Labs, Inc.|
Txns:
| Granted 50,000 options
@ $0.755, valued at
$37.8k
|
|
| 08/14/2023 |
4
| MCNALLY ROBERT T (Director) has filed a Form 4 on GeoVax Labs, Inc.|
Txns:
| Granted 50,000 options
@ $0.755, valued at
$37.8k
|
|
| 08/14/2023 |
4
| Lemerond Nicole (Director) has filed a Form 4 on GeoVax Labs, Inc.|
Txns:
| Granted 50,000 options
@ $0.755, valued at
$37.8k
|
|
| 08/14/2023 |
4
| Kollintzas Dean G (Director) has filed a Form 4 on GeoVax Labs, Inc.|
Txns:
| Granted 50,000 options
@ $0.755, valued at
$37.8k
|
|
| 08/14/2023 |
4
| CHASE RANDAL D (Director) has filed a Form 4 on GeoVax Labs, Inc.|
Txns:
| Granted 50,000 options
@ $0.755, valued at
$37.8k
|
|
| 08/14/2023 |
4
| McKee Kelly T. Jr. (Chief Medical Officer) has filed a Form 4 on GeoVax Labs, Inc.|
Txns:
| Granted 15,000 options
@ $0.755, valued at
$11.3k
|
|
| 08/14/2023 |
4
| Sharkey John W. (VP, Business Development) has filed a Form 4 on GeoVax Labs, Inc.|
Txns:
| Granted 100,000 options
@ $0.755, valued at
$75.5k
|
|
| 08/14/2023 |
4
| NEWMAN MARK J (Chief Scientific Officer) has filed a Form 4 on GeoVax Labs, Inc.|
Txns:
| Granted 100,000 options
@ $0.755, valued at
$75.5k
|
|
| 08/14/2023 |
4
| DODD DAVID A (President, CEO) has filed a Form 4 on GeoVax Labs, Inc.|
Txns:
| Granted 250,000 options
@ $0.755, valued at
$188.8k
|
|
| 08/14/2023 |
4
| Reynolds Mark (CFO) has filed a Form 4 on GeoVax Labs, Inc.|
Txns:
| Granted 100,000 options
@ $0.755, valued at
$75.5k
|
|
| 04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/23/2022 |
4
| CHASE RANDAL D (Director) has filed a Form 4 on GeoVax Labs, Inc.|
Txns:
| Bought 10,000 shares
@ $1.1, valued at
$11k
|
|
| 09/06/2022 |
3
| Lemerond Nicole (Director) has filed a Form 3 on GeoVax Labs, Inc. |
| 07/05/2022 |
4
| Sharkey John W. (VP, Business Development) has filed a Form 4 on GeoVax Labs, Inc.|
Txns:
| Bought 1,000 shares
@ $0.82, valued at
$820 |
|
| 06/28/2022 |
4
| McKee Kelly T. Jr. (Chief Medical Officer) has filed a Form 4 on GeoVax Labs, Inc.|
Txns:
| Bought 4,464 shares
@ $1.12, valued at
$5k
|
|
| 06/22/2022 |
4
| CHASE RANDAL D (Director) has filed a Form 4 on GeoVax Labs, Inc.|
Txns:
| Bought 10,000 shares
@ $1.21, valued at
$12.1k
|
|
| 06/22/2022 |
3
| Sharkey John W. (VP, Business Development) has filed a Form 3 on GeoVax Labs, Inc. |
| 05/06/2022 |
4
| McKee Kelly T. Jr. (Chief Medical Officer) has filed a Form 4 on GeoVax Labs, Inc.|
Txns:
| Bought 9,722 shares
@ $0.72, valued at
$7k
|
|
| 05/05/2022 |
4
| McKee Kelly T. Jr. (Chief Medical Officer) has filed a Form 4 on GeoVax Labs, Inc.|
Txns:
| Bought 4,999 shares
@ $0.71, valued at
$3.5k
|
|
| 01/11/2022 |
3
| McKee Kelly T. Jr. (Chief Medical Officer) has filed a Form 3 on GeoVax Labs, Inc. |
| 12/08/2021 |
4
| SPENCER JOHN N JR (Director) has filed a Form 4 on GeoVax Labs, Inc.|
Txns:
| Granted 25,000 options to buy
@ $3.82, valued at
$95.5k
|
|
| 12/08/2021 |
4
| MCNALLY ROBERT T (Director) has filed a Form 4 on GeoVax Labs, Inc.|
Txns:
| Granted 25,000 options to buy
@ $3.82, valued at
$95.5k
|
|
| 12/08/2021 |
4
| Kollintzas Dean G (Director) has filed a Form 4 on GeoVax Labs, Inc.|
Txns:
| Granted 25,000 options to buy
@ $3.82, valued at
$95.5k
|
|
| 12/08/2021 |
4
| CHASE RANDAL D (Director) has filed a Form 4 on GeoVax Labs, Inc.|
Txns:
| Granted 25,000 options to buy
@ $3.82, valued at
$95.5k
|
|
| 12/08/2021 |
4
| NEWMAN MARK J (Chief Scientific Officer) has filed a Form 4 on GeoVax Labs, Inc.|
Txns:
| Granted 25,700 options to buy
@ $3.82, valued at
$98.2k
|
|
| 12/08/2021 |
4
| Reynolds Mark (CFO) has filed a Form 4 on GeoVax Labs, Inc.|
Txns:
| Granted 48,200 options to buy
@ $3.82, valued at
$184.1k
|
|
| 12/08/2021 |
4
| DODD DAVID A (President, CEO) has filed a Form 4 on GeoVax Labs, Inc.|
Txns:
| Granted 103,000 options to buy
@ $3.82, valued at
$393.5k
|
|
| 08/11/2021 |
4
| DODD DAVID A (President, CEO) has filed a Form 4 on GeoVax Labs, Inc.|
Txns:
| Granted 273,000 options to buy
@ $2.79, valued at
$761.7k
|
|
| 08/11/2021 |
4
| Reynolds Mark (CFO) has filed a Form 4 on GeoVax Labs, Inc.|
Txns:
| Granted 128,000 options to buy
@ $2.79, valued at
$357.1k
|
|
| 08/11/2021 |
4
| NEWMAN MARK J (Chief Scientific Officer) has filed a Form 4 on GeoVax Labs, Inc.|
Txns:
| Granted 35,000 options to buy
@ $2.79, valued at
$97.7k
|
|
|
|
|